lactic acid has been researched along with guaifenesin in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 6 (27.27) | 29.6817 |
| 2010's | 14 (63.64) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Järvinen, K; Karjalainen, T; Malin, M; Pohjolainen, S; Seppälä, J; Tarvainen, T; Tuominen, J | 1 |
| Barragan, I; Järvinen, K; Malin, M; Seppälä, J; Tarvainen, T; Tuominen, J | 1 |
| Carlsöö, B; Kumlien, J; Stierna, P | 1 |
| Hase, T; Meguro, S; Sakata, T; Shimotoyodome, A; Tokimitsu, I | 1 |
| Cnattingius, S; Nordström, L; Wiberg-Itzel, E | 1 |
| Lauková, A; Ouwehand, AC; Simonová, M; Strompfová, V; Styriak, I; Várady, M | 1 |
| Cone, R; Figueiredo, A; Hanes, J; Hida, K; Hope, TJ; Lai, SK; Shukair, S; Wang, YY | 1 |
| Hagi, T; Hoshino, T; Sugimura, Y | 1 |
| Deloménie, C; Fattal, E; Hillaireau, H; Kerdine-Römer, S; Le Droumaguet, B; Mura, S; Nicolas, J; Nicolas, V; Pallardy, M; Tsapis, N | 1 |
| Everaert, A; Hermans, K; Ludwig, A; Van den Plas, D; Weyenberg, W | 1 |
| Brynskov, J; Frandsen, HL; Licht, TR; Steenholdt, C; Sulek, K; van de Wiele, T; van den Abbeele, P; Vermeiren, J; Vigsnaes, LK | 1 |
| Al Jamal, KT; Alpar, O; Awad, G; El-Shamy, AE; Kan, PL; Mortada, N; Osman, R | 1 |
| Choi, SY; Choy, YB; Kim, MJ; Lee, JE; Lee, SH; Park, CG; Park, KH; Park, M; Shin, GS | 1 |
| Han, XY; Lv, MY; Ma, YF; Qian, LC; Wu, ZP | 1 |
| Abdulkarim, M; Agulló, N; Bernkop-Schnürch, A; Borros, SG; Cattoz, B; Griffiths, P; Gumbleton, M | 1 |
| Chater, PI; Pearson, JP; Pereira de Sousa, I; Van Rooij, LK; Wilcox, MD | 1 |
| González, MP; Marín, SL; Vargas-Chacoff, L | 1 |
| Cone, R; Harit, D; Humphrys, MS; Lai, SK; Ma, B; Nunn, KL; Ravel, J; Wang, YY | 1 |
| Günday Türeli, N; Juntke, J; Lehr, CM; Schneider, M; Schneider-Daum, N; Schwarz, BC; Torge, A; Türeli, AE | 1 |
| Ong, HX; Pisano, E; Scalia, S; Traini, D; Tulbah, AS; Young, PM | 1 |
| Anderski, J; Langer, K; Mahlert, L; Mulac, D | 1 |
| Deng, L; Feng, Y; Li, R; Ouyang, Q; Qin, M; Sun, J; Wang, F; Wang, H; Wu, J; Yang, T; Yu, Q; Zhai, T; Zhan, Q | 1 |
22 other study(ies) available for lactic acid and guaifenesin
| Article | Year |
|---|---|
Degradation of and drug release from a novel 2,2-bis(2-oxazoline) linked poly(lactic acid) polymer.
Topics: Biocompatible Materials; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Dextrans; Drug Carriers; Fluorescein-5-isothiocyanate; Guaifenesin; Lactic Acid; Microspheres; Molecular Weight; Oxazoles; Polyesters; Polymers; Sodium Salicylate; Time Factors; Timolol | 2002 |
Effects of incorporated drugs on degradation of novel 2,2'-bis(2-oxazoline) linked poly(lactic acid) films.
Topics: Drug Delivery Systems; Guaifenesin; Kinetics; Lactic Acid; Molecular Weight; Polyesters; Polymers; Sodium Salicylate; Solubility; Timolol | 2006 |
Experimental sinusitis in rabbits induced by aerobic and anaerobic bacteria: models for research in sinusitis.
Topics: Animals; Bacteroides fragilis; Bacteroides Infections; Blood Flow Velocity; Disease Models, Animal; Lactates; Lactic Acid; Microspheres; Mucus; Pneumococcal Infections; Rabbits; Serotyping; Sinusitis | 1991 |
Short chain fatty acids but not lactate or succinate stimulate mucus release in the rat colon.
Topics: Animals; Butyrates; Colon; Fatty Acids, Volatile; Lactic Acid; Male; Mucus; Rats; Rats, Sprague-Dawley; Succinic Acid | 2000 |
Lactate determination in vaginal fluids: a new method in the diagnosis of prelabour rupture of membranes.
Topics: Adult; Cervix Mucus; Female; Fetal Membranes, Premature Rupture; Humans; Lactic Acid; Middle Aged; Mucus; Predictive Value of Tests; Pregnancy; Prospective Studies; ROC Curve; Sensitivity and Specificity; Vagina | 2005 |
Potential of enterococci isolated from horses.
Topics: Animals; Anti-Bacterial Agents; Apoproteins; Bacterial Adhesion; Bacterial Proteins; Bridged-Ring Compounds; Colony Count, Microbial; Drug Resistance, Bacterial; Enterococcus; Feces; Fibronectins; Genes, Bacterial; Horses; Lactic Acid; Lactoferrin; Mucus; Probiotics; Protein Binding; Slovakia; Transferrin; Urease | 2008 |
Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus.
Topics: Animals; Cell Line; Cervix Uteri; Disease Models, Animal; Female; HIV Infections; HIV-1; Humans; Hydrogen-Ion Concentration; Lactic Acid; Lactobacillus; Mucus; Surface Properties; Vagina; Virion | 2009 |
Correlation between in vitro mucus adhesion and the in vivo colonization ability of lactic acid bacteria: screening of new candidate carp probiotics.
Topics: Animals; Bacterial Adhesion; Bacterial Typing Techniques; Carps; Colony Count, Microbial; Intestinal Mucosa; Intestines; Lactic Acid; Lactobacillaceae; Mucus; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Probiotics; Statistics as Topic | 2011 |
Biodegradable nanoparticles meet the bronchial airway barrier: how surface properties affect their interaction with mucus and epithelial cells.
Topics: Bronchi; Cell Line; Electric Impedance; Epithelial Cells; Gene Expression; Humans; Lactic Acid; Mucin 5AC; Mucus; Nanoparticles; Permeability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties | 2011 |
Full factorial design, physicochemical characterisation and biological assessment of cyclosporine A loaded cationic nanoparticles.
Topics: Animals; Cations; Chitosan; Cyclosporine; Drug Carriers; Drug Compounding; Emulsions; Epithelial Cells; Humans; Immunosuppressive Agents; Jurkat Cells; Lactic Acid; Mucus; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solvents; Static Electricity; Swine; Tears | 2012 |
Microbiotas from UC patients display altered metabolism and reduced ability of LAB to colonize mucus.
Topics: Bacteria; Colitis, Ulcerative; Feces; Gastrointestinal Tract; Humans; Intestinal Mucosa; Lactic Acid; Metabolome; Metagenome; Mucins; Mucus | 2013 |
Inhalable DNase I microparticles engineered with biologically active excipients.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Aerosols; Animals; Chitosan; Cystic Fibrosis; Delayed-Action Preparations; Deoxyribonuclease I; Dextrans; Drug Carriers; Drug Delivery Systems; Epithelial Cells; Excipients; Lactic Acid; Macrophages; Mice; Mucus; Ovalbumin; Polyglutamic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Powders; Viscosity | 2013 |
Nanostructured mucoadhesive microparticles for enhanced preocular retention.
Topics: Adhesiveness; Animals; Chemistry, Pharmaceutical; Eye; Lactic Acid; Male; Microscopy, Fluorescence; Microspheres; Mucus; Nanostructures; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Tablets | 2014 |
Chitosan-zinc chelate improves intestinal structure and mucosal function and decreases apoptosis in ileal mucosal epithelial cells in weaned pigs.
Topics: Amine Oxidase (Copper-Containing); Animals; Apoptosis; Biological Availability; Chelating Agents; Chitosan; Diet; Dietary Supplements; Endotoxins; Epithelial Cells; Ileum; Immunoglobulin A, Secretory; In Situ Nick-End Labeling; Intestinal Mucosa; Intestine, Small; Lactic Acid; Male; Mucus; Swine; Weaning; Zinc | 2014 |
Nanoparticle diffusion within intestinal mucus: Three-dimensional response analysis dissecting the impact of particle surface charge, size and heterogeneity across polyelectrolyte, pegylated and viral particles.
Topics: Acrylic Resins; Animals; Biological Transport; Chitosan; Diffusion; Electrolytes; Jejunum; Lactic Acid; Microscopy, Atomic Force; Mucus; Nanoparticles; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rheology; Surface Properties; Swine; Virion | 2015 |
The effect of nanoparticle permeation on the bulk rheological properties of mucus from the small intestine.
Topics: Abattoirs; Acrylic Resins; Ananas; Animals; Bromelains; Drug Carriers; Enzymes, Immobilized; Glycoproteins; Intestinal Mucosa; Intestine, Small; Lactic Acid; Mucus; Nanoparticles; Permeability; Plant Proteins; Plant Stems; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rheology; Surface Properties; Sus scrofa; Viscosity | 2015 |
Stress response of Salmo salar (Linnaeus 1758) when heavily infested by Caligus rogercresseyi (Boxshall & Bravo 2000) copepodids.
Topics: Amino Acids; Animals; Blood Glucose; Blood Proteins; Copepoda; Ectoparasitic Infestations; Female; Fish Diseases; Fish Proteins; Hydrocortisone; Lactic Acid; Mucus; Salmo salar; Skin; Stress, Physiological; Triglycerides | 2016 |
Enhanced Trapping of HIV-1 by Human Cervicovaginal Mucus Is Associated with Lactobacillus crispatus-Dominant Microbiota.
Topics: Adult; Cervix Uteri; Female; Gardnerella vaginalis; HIV-1; Humans; Hydrogen-Ion Concentration; Lactic Acid; Lactobacillus; Mucus; Vagina; Young Adult | 2015 |
Ciprofloxacin-loaded PLGA nanoparticles against cystic fibrosis P. aeruginosa lung infections.
Topics: Animals; Cell Line; Ciprofloxacin; Cystic Fibrosis; Drug Carriers; Horses; Humans; Lactic Acid; Mucus; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pseudomonas aeruginosa; Respiratory Mucosa; Respiratory Tract Infections | 2017 |
Inhaled simvastatin nanoparticles for inflammatory lung disease.
Topics: Administration, Inhalation; Anti-Inflammatory Agents; Biological Transport; Chemistry, Pharmaceutical; Chronic Disease; Drug Carriers; Drug Liberation; Epithelial Cells; Humans; Inflammation; Lactic Acid; Lung Diseases; Mucus; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Simvastatin; Surface Properties | 2017 |
Mucus-penetrating nanoparticles: Promising drug delivery systems for the photodynamic therapy of intestinal cancer.
Topics: Administration, Oral; Caco-2 Cells; Chitosan; Drug Delivery Systems; Humans; Intestinal Mucosa; Intestinal Neoplasms; Lactic Acid; Mucus; Nanoparticles; Permeability; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porphyrins | 2018 |
Mucus-permeable polymyxin B-hyaluronic acid/ poly (lactic-co-glycolic acid) nanoparticle platform for the nebulized treatment of lung infections.
Topics: Animals; Drug Carriers; Drug Delivery Systems; Glycolates; Hyaluronic Acid; Lactic Acid; Lung; Mice; Mucus; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymyxin B | 2022 |